1. Construction of ROS-Responsive Hyaluronic Acid Modified Paclitaxel and Diosgenin Liposomes and Study on Synergistic Enhancement of Anti-Ovarian Cancer Efficacy.
- Author
-
Tang L, Wang YJ, Wang YY, Li ST, Kong L, Li XT, Ma LL, and Liu XX
- Subjects
- Female, Cell Line, Tumor, Animals, Humans, Drug Synergism, Cell Proliferation drug effects, Cell Movement drug effects, Mice, Mice, Inbred BALB C, Mice, Nude, Phosphatidylethanolamines, Liposomes chemistry, Liposomes pharmacokinetics, Paclitaxel pharmacology, Paclitaxel chemistry, Paclitaxel pharmacokinetics, Paclitaxel administration & dosage, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Diosgenin pharmacology, Diosgenin chemistry, Diosgenin pharmacokinetics, Diosgenin administration & dosage, Hyaluronic Acid chemistry, Hyaluronic Acid pharmacology, Polyethylene Glycols chemistry, Reactive Oxygen Species metabolism, Apoptosis drug effects
- Abstract
Purpose: Ovarian cancer is a fatal gynecologic malignancy with a high rate of abdominal metastasis. Chemotherapy still has a poor clinical prognosis for ovarian cancer patients, with cell proliferation and angiogenesis leading to invasion, migration, and recurrence. To overcome these obstacles, we constructed a novel HA-modified paclitaxel and diosgenin liposome (PEG-TK-HA-PDLPs) using two novel functional materials, DSPE-PEG
2000 -HA and DSPE-PEG2000 -TK-PEG5000 , to specifically deliver the drugs to the tumor site in order to reduce OC cell proliferation and anti-angiogenic generation, thereby inhibiting invasion and migration., Methods and Results: PEG-TK-HA-PDLPs were prepared by film dispersion, with ideal physicochemical properties and exhibits active targeting for enhanced cellular uptake. The ZIP synergy score for PTX and Dios was calculated using the online SynergyFinder software to be 3.15, indicating synergy. In vitro results showed that PEG-TK-HA-PDLPs were highly cytotoxic to ID8 cells, induced ID8 cell apoptosis, and inhibited ID8 cell migration and invasion. In vivo studies showed that PEG-TK-HA-PDLPs could prolong the circulation time in the blood, accumulate significantly in the tumor site, and effectively fight against angiogenesis with significant anti-tumor effects., Conclusion: The production of PEG-TK-HA-PDLPs is an effective strategy for the treatment of OC., Competing Interests: The authors report no potential conflicts of interest in this work., (© 2024 Tang et al.)- Published
- 2024
- Full Text
- View/download PDF